Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.

Dubaquié Y, Mortensen DL, Intintoli A, Hogue DA, Nakamura G, Rancatore P, Lester P, Sadick MD, Filvaroff E, Fielder PJ, Lowman HB.

Endocrinology. 2001 Jan;142(1):165-73.

PMID:
11145579
2.

Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeys.

Nguyen CB, Harris L, Szönyi E, Baughman SA, Hale VG, Dybdal NO, Sadick MD, Escandón E.

Drug Metab Dispos. 2000 May;28(5):598-607.

PMID:
10772641
3.

Stability and interactions of recombinant human nerve growth factor in different biological matrices: in vitro and in vivo studies.

Nguyen CB, Szönyi E, Sadick MD, Hotaling TE, Mendoza-Ramirez JL, Escandón E.

Drug Metab Dispos. 2000 May;28(5):590-7.

PMID:
10772640
4.

Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays.

Sadick MD, Intintoli A, Quarmby V, McCoy A, Canova-Davis E, Ling V.

J Pharm Biomed Anal. 1999 May;19(6):883-91.

PMID:
10698554
5.
6.

Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.

Lowman HB, Chen YM, Skelton NJ, Mortensen DL, Tomlinson EE, Sadick MD, Robinson IC, Clark RG.

Biochemistry. 1998 Jun 23;37(25):8870-8.

PMID:
9636028
7.

Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay.

Sadick MD, Galloway A, Shelton D, Hale V, Weck S, Anicetti V, Wong WL.

Exp Cell Res. 1997 Aug 1;234(2):354-61.

PMID:
9260905
8.

Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assay.

Sadick MD, Sliwkowski MX, Nuijens A, Bald L, Chiang N, Lofgren JA, Wong WL.

Anal Biochem. 1996 Mar 15;235(2):207-14.

PMID:
8833330
9.

Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3.

Godowski PJ, Mark MR, Chen J, Sadick MD, Raab H, Hammonds RG.

Cell. 1995 Aug 11;82(3):355-8. No abstract available.

10.

Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi.

Holaday BJ, Pompeu MM, Evans T, Braga DN, Texeira MJ, Sousa Ade Q, Sadick MD, Vasconcelos AW, Abrams JS, Pearson RD, et al.

J Infect Dis. 1993 Feb;167(2):411-7.

PMID:
8421174
11.
12.

Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.

Holaday BJ, Sadick MD, Wang ZE, Reiner SL, Heinzel FP, Parslow TG, Locksley RM.

J Immunol. 1991 Sep 1;147(5):1653-8.

PMID:
1831830
13.
14.

Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection.

Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, Sadick MD.

Res Immunol. 1991 Jan;142(1):28-32. Review. No abstract available.

PMID:
1829257
15.
17.

Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Locksley RM, Crowe S, Sadick MD, Heinzel FP, Gardner KD Jr, McGrath MS, Mills J.

J Clin Invest. 1988 Dec;82(6):2097-105.

18.

Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.

Holaday B, Sadick MD, Pearson RD.

J Immunol. 1988 Sep 15;141(6):2132-7.

PMID:
3262649
19.
20.
21.

Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets.

Locksley RM, Heinzel FP, Sadick MD, Holaday BJ, Gardner KD Jr.

Ann Inst Pasteur Immunol. 1987 Sep-Oct;138(5):744-9.

PMID:
2964247
22.

Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.

Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.

J Immunol. 1987 Aug 15;139(4):1303-9.

PMID:
3112230
23.
24.

Leishmania tropica: differences in the antigenicity of promastigotes and amastigotes.

Sadick MD, Raff HV.

Cell Immunol. 1985 Apr 1;91(2):404-14.

PMID:
3873282
26.

Development of cellular immunity in cutaneous leishmaniasis due to Leishmania tropica.

Sadick MD, Locksley RM, Raff HV.

J Infect Dis. 1984 Jul;150(1):135-8.

PMID:
6611378

Supplemental Content

Loading ...
Support Center